Mitomycin 40 MG Injection — RxCUI 1740898
RxNorm drug concept · Semantic clinical drug
RxCUI 1740898
Semantic clinical drug · SCD
● Current RxNorm concept 25 FDA products
25 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1740898
Official nameMitomycin 40 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped25
Package NDCs mapped25
Reported Medicaid activity (SDUD)48 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Mitomycin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Mitomycin is a chemotherapy drug used for several different conditions depending on the product form. The intravenous versions — Mitomycin for Injection and Mutamycin — are used al...
- The intravenous form is given through a vein by a trained healthcare professional, usually in a hospital or cancer clinic — you won't take it at home as a pill. It's typically give...
- How will I receive my mitomycin treatment?
- The most important thing to watch for is signs of low blood cell counts — things like fever, chills, unusual fatigue, or easy bruising and bleeding. These can be serious and need p...
🕸️ Concept Web — How Mitomycin 40 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Mitomycin 40 MG Injection
RxCUI 1740898 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Mitomycin
632IN
-
Mitomycin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Mutamycin
204298BN
-
Mutamycin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Mitomycin Injection
1740893SCDF -
Mitomycin Injectable Product
1165372SCDG -
Mitomycin Injection [Mutamycin]
1812478SBDF -
Mutamycin Injectable Product
1812479SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Mitomycin Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Mitomycin 40 MG
1740897SCDC -
Mitomycin 40 MG Injection [Mutamycin]
1812482SBD -
Mitomycin 40 MG [Mutamycin]
1812481SBDC
-
Mitomycin 40 MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Mitomycin 40 MG
SCDC · 1740897 -
Mitomycin Injection
SCDF · 1740893 -
Mitomycin Injectable Product
SCDG · 1165372
Brand-Name Concepts
-
Mitomycin 40 MG Injection [Mutamycin]
SBD · 1812482 -
Mitomycin 40 MG [Mutamycin]
SBDC · 1812481 -
Mitomycin Injection [Mutamycin]
SBDF · 1812478 -
Mutamycin Injectable Product
SBDG · 1812479 -
Mutamycin
BN · 204298
📦 FDA Products & Package NDCs
25 products · 25 package NDCs
25 package NDCs map to RxCUI 1740898 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9135-01 | 1 VIAL in 1 BOX (0143-9135-01) / 1 INJECTION, POWDER, LYOPH... | Mitomycin | Hikma Pharmaceuticals USA Inc. | 2022-10-01 |
| 00143-9136-01 | 1 VIAL in 1 BOX (0143-9136-01) / 1 INJECTION, POWDER, LYOPH... | Mitomycin | Hikma Pharmaceuticals USA Inc. | 2022-10-01 |
| 00143-9279-01 | 1 VIAL in 1 BOX, UNIT-DOSE (0143-9279-01) / 40 mL in 1 VIAL | Mitomycin | Hikma Pharmaceuticals USA Inc. | 1996-05-01 |
| 00143-9280-01 | 1 VIAL in 1 BOX, UNIT-DOSE (0143-9280-01) / 80 mL in 1 VIAL | Mitomycin | Hikma Pharmaceuticals USA Inc. | 1999-09-01 |
| 16729-0108-11 | 1 VIAL in 1 BOX, UNIT-DOSE (16729-108-11) / 40 mL in 1 VIAL | Mitomycin | Accord Healthcare, Inc. | 2009-06-10 |
| 16729-0115-05 | 1 VIAL in 1 CARTON (16729-115-05) / 10 mL in 1 VIAL | Mitomycin | Accord Healthcare, Inc. | 2009-06-18 |
| 16729-0116-38 | 1 VIAL in 1 BOX, UNIT-DOSE (16729-116-38) / 80 mL in 1 VIAL | Mitomycin | Accord Healthcare, Inc. | 2011-03-11 |
| 25021-0252-51 | 1 VIAL in 1 CARTON (25021-252-51) / 80 mL in 1 VIAL | Mitomycin | Sagent Pharmaceuticals | 2023-06-15 |
| 55150-0450-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-450-01) / 10 mL in 1... | MITOMYCIN | Eugia US LLC | 2023-10-30 |
| 55150-0451-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-451-01) / 40 mL in 1... | MITOMYCIN | Eugia US LLC | 2023-10-30 |
| 55150-0452-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-452-01) / 80 mL in 1... | MITOMYCIN | Eugia US LLC | 2023-10-30 |
| 65219-0568-00 | 1 VIAL, SINGLE-DOSE in 1 CARTON (65219-568-00) / 80 mL in 1... | MITOMYCIN | Fresenius Kabi USA, LLC | 2023-01-15 |
| 68001-0389-36 | 1 VIAL in 1 CARTON (68001-389-36) / 10 mL in 1 VIAL (68001-... | Mitomycin | BluePoint Laboratories | 2019-05-14 |
| 68001-0390-77 | 1 VIAL in 1 BOX, UNIT-DOSE (68001-390-77) / 40 mL in 1 VIAL... | Mitomycin | BluePoint Laboratories | 2019-05-14 |
| 68001-0391-79 | 1 VIAL in 1 BOX, UNIT-DOSE (68001-391-79) / 80 mL in 1 VIAL... | Mitomycin | BluePoint Laboratories | 2019-05-14 |
| 68001-0615-36 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-615-36) / 10 mL in 1... | MITOMYCIN | BluePoint Laboratories | 2024-07-08 |
| 68001-0616-77 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-616-77) / 40 mL in 1... | MITOMYCIN | BluePoint Laboratories | 2024-06-24 |
| 68001-0617-79 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-617-79) / 80 mL in 1... | MITOMYCIN | BluePoint Laboratories | 2024-07-11 |
| 68083-0502-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-502-01) / 80 mL in 1... | MITOMYCIN | Gland Pharma Limited | 2022-11-22 |
| 69448-0001-05 | 1 VIAL in 1 CARTON (69448-001-05) / 10 mL in 1 VIAL | MUTAMYCIN | Accord BioPharma Inc. | 2017-07-25 |
| 69448-0003-38 | 1 VIAL in 1 BOX, UNIT-DOSE (69448-003-38) / 80 mL in 1 VIAL | MUTAMYCIN | Accord BioPharma Inc. | 2017-07-25 |
| 71288-0139-51 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-139-51) / 80 mL in 1... | MITOMYCIN | Meitheal Pharmaceuticals Inc. | 2022-09-06 |
| 72819-0152-05 | 1 VIAL in 1 CARTON (72819-152-05) / 10 mL in 1 VIAL | Mitomycin | Archis Pharma LLC | 2022-04-25 |
| 72819-0153-02 | 1 VIAL in 1 CARTON (72819-153-02) / 40 mL in 1 VIAL | Mitomycin | Archis Pharma LLC | 2022-04-25 |
| 72819-0154-04 | 1 VIAL in 1 CARTON (72819-154-04) / 80 mL in 1 VIAL | Mitomycin | Archis Pharma LLC | 2022-04-25 |
Observed labelers:
BluePoint Laboratories (6) ·
Hikma Pharmaceuticals USA Inc. (4) ·
Accord Healthcare, Inc. (3) ·
Archis Pharma LLC (3) ·
Eugia US LLC (3) ·
Accord BioPharma Inc. (2)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9280 | Mitomycin injection | 19 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.